Mm.3336
|
RIKEN cDNA 1110007C09 gene (1110007C09Rik)
|
2.66 ± 1.63
|
3.68 ± 1.14
|
6.81 ± 4.35
|
5.22 ± 0.66
|
Mm.277585
|
amyloid beta (A4) precursor protein (App)
|
2.50 ± 0.48
|
2.54 ± 0.59
|
4.05 ± 1.20
|
2.87 ± 0.42
|
Mm.84073
|
Bcl2-associated athanogene 3 (Bag3)
|
2.63 ± 0.59
|
3.30 ± 0.43
|
4.61 ± 2.37
|
4.23 ± 0.18
|
Mm.29820
|
BCL2/adenovirus E1B 19kDa-interacting protein 3-like (Bnip3l)
|
1.96 ± 0.11
|
2.52 ± 0.04
|
3.88 ± 2.19
|
3.07 ± 0.14
|
Mm.290908
|
baculoviral IAP repeat-containing 6 (Birc6), mRNA.
|
1.94 ± 0.33
|
2.15 ± 0.22
|
2.54 ± 0.93
|
2.18 ± 0.04
|
Mm.283714
|
sialophorin (Spn), mRNA.
|
1.99 ± 0.14
|
2.50 ± 0.19
|
2.87 ± 1.63
|
2.25 ± 0.24
|
Mm.2381
|
amyloid beta (A4) precursor-like protein 1 (Aplp1),
|
NE
|
1.90 ± 0.06
|
3.70 ± 1.15
|
2.27 ± 0.14
|
Mm.200608
|
Clusterin (Clu)
|
NE
|
1.74 ± 0.13
|
4.03 ± 1.54
|
2.45 ± 0.37
|
Mm.136224
|
interferon induced with helicase C domain 1 (Ifih1)
|
NE
|
3.59/-
|
5.21 ± 1.05
|
4.18 ± 0.31
|
Mm.4266
|
integral membrane protein 2B (Itm2b)
|
NE
|
1.55 ± 0.20
|
2.43 ± 0.95
|
2.46 ± 0.54
|
Mm.2326
|
macrophage migration inhibitory factor (Mif)
|
NE
|
1.08 ± 0.17
|
2.25 ± 0.53
|
2.06 ± 0.07
|
Mm.277518
|
Monocyte to macrophage differentiation-associated (Mmd)
|
NE
|
0.59 ± 0.04
|
2.33 ± 0.45
|
1.64 ± 0.18
|
Mm.347546
|
Inositol 1,3,4-triphosphate 5/6 kinase
|
NE
|
1.94 ± 0.02
|
0.95 ± 0.05
|
1.83 ± 0.02
|
Mm.285322
|
mitochondrial carrier homolog 1 (C. elegans) (Mtch1)
|
NE
|
0.95 ± 0.01
|
2.08 ± 0.35
|
1.77 ± 0.23
|
Mm.687
|
Ras homolog gene family, member B (Rhob)
|
NE
|
1.17 ± 0.03
|
2.48 ± 0.87
|
1.59 ± 0.15
|
Mm.379457
|
Valosin containing protein (Vcp)
|
NE
|
1.68 ± 0.15
|
2.04 ± 0.77
|
1.80 ± 0.17
|
Mm.6826
|
Apoptosis-associated tyrosine kinase (Aatk)
|
NE
|
NE
|
1.65 ± 0.07
|
1.20 ± 0.43
|
Mm.223689
|
Bifunctional apoptosis regulator (Bfar)
|
NE
|
NE
|
1.83 ± 0.58
|
1.70 ± 0.08
|
Mm.130832
|
caspase recruitment domain family, member 14 (Card14)
|
NE
|
NE
|
3.23 ± 1.52
|
2.69 ± 0.08
|
Mm.29028
|
Death associated protein 3 (Dap3)
|
NE
|
NE
|
1.87 ± 0.14
|
0.96 ± 0.03
|
Mm.280594
|
Death effector domain-containing DNA binding protein 2 (Dedd2)
|
NE
|
NE
|
1.79 ± 0.66
|
1.92 ± 0.09
|
Mm.379461
|
eukaryotic translation initiation factor 5A (Eif5a)
|
NE
|
NE
|
2.61 ± 0.49
|
1.92 ± 0.14
|
Mm.342392
|
engulfment and cell motility 1, ced-12 homolog (C. elegans) (Elmo1), transcript variant 2
|
NE
|
NE
|
1.74 ± 0.21
|
1.41 ± 0.08
|
Mm.39760
|
Fas apoptotic inhibitory molecule 2 (Faim2)
|
NE
|
NE
|
2.85 ± 1.23
|
2.44 ± 0.12
|
Mm.281298
|
growth arrest and DNA-damage-inducible 45 gamma (Gadd45g)
|
NE
|
NE
|
3.16 ± 0.21
|
2.12 ± 0.05
|
Mm.15510
|
granzyme A (Gzma)
|
NE
|
NE
|
1.27 ± 0.41
|
1.94 ± 0.26
|
Mm.2720
|
Mitogen activated protein kinase 8 interacting protein 1 (Mapk8ip1)
|
NE
|
NE
|
2.25 ± 0.75
|
1.16 ± 0.19
|
Mm.1639
|
Myeloid cell leukemia sequence 1 (Mcl1)
|
NE
|
NE
|
1.83 ± 0.18
|
1.56 ± 0.09
|
Mm.204876
|
nucleolar protein 3 (apoptosis repressor with CARD domain) (Nol3)
|
NE
|
NE
|
2.02 ± 0.52
|
1.84 ± 0.09
|
Mm.24163
|
PYD and CARD domain containing (Pycard)
|
NE
|
NE
|
1.82 ± 0.17
|
1.38 ± 0.18
|
Mm.276325
|
superoxide dismutase 1, soluble (Sod1)
|
NE
|
NE
|
1.74 ± 0.22
|
1.54 ± 0.24
|
Mm.200792
|
tumor necrosis factor receptor superfamily, member 21 (Tnfrsf21)
|
NE
|
NE
|
2.37 ± 0.84
|
1.40 ± 0.17
|
Mm.1894
|
CD1d1 antigen (Cd1d1)
|
NE
|
NE
|
NE
|
1.56 ± 0.01
|
Mm.217764
|
phosphoglucomutase 2 (Pgm2)/Itgb3bp
|
NE
|
NE
|
NE
|
1.63 ± 0.11
|
Mm.312628
|
Serine (or cysteine) proteinase inhibitor, clade A, member 3G (Serpina3g)
|
NE
|
NE
|
NE
|
2.83 ± 0.18
|
Mm.218473
|
tumor differentially expressed 1 (Tde1)/Serinc3
|
NE
|
NE
|
NE
|
1.94 ± 0.01
|
Mm.338613
|
forkhead box O3a (Foxo3a)
|
1.92 ± 0.17
|
NE
|
2.26 ± 1.08
|
1.57 ± 0.03
|
Mm.22216
|
TSC22 domain family 3 (Tcs22d3)
|
NE
|
1.63 ± 0.20
|
NE
|
NE
|
Mm.1360
|
growth arrest and DNA-damage-inducible 45 beta (Gadd45b)
|
NE
|
2.00 ± 0.33
|
NE
|
1.85 ± 0.03
|
Mm.329277
|
ubiquitin specific peptidase 14 (Usp14)/Thoc1
|
NE
|
1.90 ± 0.21
|
NE
|
2.02 ± 0.18
|
Mm.347406
|
CCAAT/enhancer binding protein (C/EBP), beta (Cebpb)
|
NE
|
NE
|
2.01 ± 0.17
|
NE
|
Mm.150
|
Fc receptor, IgG, high affinity 1(Fcgr1)
|
NE
|
NE
|
2.26 ± 0.26
|
NE
|
Mm.292100
|
fibrinogen-like protein 2 (Fgl2)
|
NE
|
NE
|
1.90 ± 0.27
|
NE
|
Mm.368515
|
myc-like oncogene, s-myc protein (Mycs)
|
NE
|
NE
|
3.11 ± 0.05
|
NE
|